Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kryssia Isabel Rodriguez Castro

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Acta Bio-Medica : Atenei Parmensis|December 19, 2018
Autoimmune diseases in autoimmune atrophic gastritisKryssia Isabel Rodriguez-Castro, Marilisa Franceschi, Chiara Miraglia, et al.
Acta Bio-Medica : Atenei Parmensis|September 14, 2020
Functional DyspesiaPellegrino Crafa, Marilisa Franceschi, Kryssia Isabel Rodriguez Castro, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|September 4, 2023
A comparison of different symptomatic reflux esophagitis treatments: A real-world studyFrancesco Di Mario, Pellegrino Crafa, Lorella Franzoni, et al.
International Journal of Molecular Sciences|February 11, 2023
Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological MarkersMichele Russo, Kryssia Isabel Rodriguez-Castro, Marilisa Franceschi, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|August 22, 2025
Proton Pump Inhibitor Challenge to Confirm Diagnosis of Atrophic Gastritis of the Stomach: A ProposalFrancesco Di Mario, Marilisa Franceschi, Kryssia Isabel Rodriguez-Castro, et al.
Acta Bio-Medica : Atenei Parmensis|December 19, 2018
Epidemiology and risk factors of pancreatic cancerMario Capasso, Marilisa Franceschi, Kryssia Isabel Rodriguez-Castro, et al.
Transplantation|March 1, 2012
Infections and organ transplantation: new challenges for prevention and treatment--a colloquiumPaolo A Grossi, Alessandro Nanni Costa, Deirdre Fehily, et al.
Expert Opinion on Biological Therapy|December 14, 2021
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in ItalyAntonio Tursi, Giammarco Mocci, Leonardo Allegretta, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Acta Bio-Medica : Atenei Parmensis|December 19, 2018
Autoimmune diseases in autoimmune atrophic gastritisKryssia Isabel Rodriguez-Castro, Marilisa Franceschi, Chiara Miraglia, et al.
Acta Bio-Medica : Atenei Parmensis|September 14, 2020
Functional DyspesiaPellegrino Crafa, Marilisa Franceschi, Kryssia Isabel Rodriguez Castro, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|September 4, 2023
A comparison of different symptomatic reflux esophagitis treatments: A real-world studyFrancesco Di Mario, Pellegrino Crafa, Lorella Franzoni, et al.
International Journal of Molecular Sciences|February 11, 2023
Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological MarkersMichele Russo, Kryssia Isabel Rodriguez-Castro, Marilisa Franceschi, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|August 22, 2025
Proton Pump Inhibitor Challenge to Confirm Diagnosis of Atrophic Gastritis of the Stomach: A ProposalFrancesco Di Mario, Marilisa Franceschi, Kryssia Isabel Rodriguez-Castro, et al.
Acta Bio-Medica : Atenei Parmensis|December 19, 2018
Epidemiology and risk factors of pancreatic cancerMario Capasso, Marilisa Franceschi, Kryssia Isabel Rodriguez-Castro, et al.
Transplantation|March 1, 2012
Infections and organ transplantation: new challenges for prevention and treatment--a colloquiumPaolo A Grossi, Alessandro Nanni Costa, Deirdre Fehily, et al.
Expert Opinion on Biological Therapy|December 14, 2021
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in ItalyAntonio Tursi, Giammarco Mocci, Leonardo Allegretta, et al.
Pageof 2